These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6996553)

  • 21. Pantethine and cystamine deplete cystine from cystinotic fibroblasts via efflux of cysteamine-cysteine mixed disulfide.
    Butler JD; Zatz M
    J Clin Invest; 1984 Aug; 74(2):411-6. PubMed ID: 6746900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulphur amino-acid degradation in subjects with hereditary glutathione synthetase deficiency (5-oxoprolinuria).
    Mårtensson J; Kågedal B; Larsson A
    Eur J Clin Invest; 1985 Dec; 15(6):371-4. PubMed ID: 3938407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of cysteamine therapy in nephropathic cystinosis.
    Yudkoff M; Foreman JW; Segal S
    N Engl J Med; 1981 Jan; 304(3):141-5. PubMed ID: 7442733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intra-leukocyte cystine in cystinosis treated with cysteamine].
    Ged C; Jean G; Tete MJ; Broyer M; Kamoun P
    Ann Biol Clin (Paris); 1991; 49(9):482-6. PubMed ID: 1789502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Morphological and biochemical investigations of hairs in inborn errors of amino acid metabolism (author's transl)].
    Wiest LG; Lutz P; Jung EG; Paweletz N
    Arch Dermatol Res (1975); 1976 Jul; 256(1):53-65. PubMed ID: 962381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uptake and utilization of exogenous cystine by cystinotic and normal fibroblasts.
    States B; Harris D; Segal S
    J Clin Invest; 1974 Apr; 53(4):1003-16. PubMed ID: 4815074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tyrosinaemia type 1 and glutathione synthetase deficiency: two disorders with reduced hepatic thiol group concentrations and a liver 4-fumarylacetoacetate hydrolase deficiency.
    Lloyd AJ; Gray RG; Green A
    J Inherit Metab Dis; 1995; 18(1):48-55. PubMed ID: 7623442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A therapeutic trial with N-acetylcysteine in subjects with hereditary glutathione synthetase deficiency (5-oxoprolinuria).
    Mårtensson J; Gustafsson J; Larsson A
    J Inherit Metab Dis; 1989; 12(2):120-30. PubMed ID: 2502672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulfur amino acids, hyperglycinemia, and certain possibly benign conditions.
    Frimpter GW
    Clin Perinatol; 1976 Mar; 3(1):53-9. PubMed ID: 954345
    [No Abstract]   [Full Text] [Related]  

  • 30. [Inherited metabolic disorders of the transsulfuration pathway].
    Haraguchi H
    Nihon Rinsho; 1992 Jul; 50(7):1548-54. PubMed ID: 1404882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced oxygen enhancement of the radiosensitivity of glutathione-deficient fibroblasts.
    Malaise EP
    Radiat Res; 1983 Sep; 95(3):486-94. PubMed ID: 6611861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glutathione precursors replenish decreased glutathione pool in cystinotic cell lines.
    Chol M; Nevo N; Cherqui S; Antignac C; Rustin P
    Biochem Biophys Res Commun; 2004 Nov; 324(1):231-5. PubMed ID: 15465007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gas Chromatography Mass Spectrometry Aided Diagnosis of Glutathione Synthetase Deficiency.
    Kaur P; Chaudhry C; Panigrahi I; Srivastava P; Kaur A
    Lab Med; 2022 May; 53(3):e59-e61. PubMed ID: 34791353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glutathione synthetase deficiency: a novel mutation with femur agenesis.
    Guney Varal I; Dogan P; Gorukmez O; Dorum S; Akdag A
    Fetal Pediatr Pathol; 2020 Feb; 39(1):38-44. PubMed ID: 31198081
    [No Abstract]   [Full Text] [Related]  

  • 35. Enhancement of glutathione content in glutathione synthetase-deficient fibroblasts from a patient with 5-oxoprolinuria via metabolic cooperation with normal fibroblasts.
    Kavanagh TJ; Raghu G; White CC; Martin GM; Rabinovitch PS; Eaton DL
    Exp Cell Res; 1994 May; 212(1):69-76. PubMed ID: 7909755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose vitamin E therapy in glutathione synthetase deficiency.
    Pejaver RK; Watson AH
    J Inherit Metab Dis; 1994; 17(6):749-50. PubMed ID: 7707700
    [No Abstract]   [Full Text] [Related]  

  • 37. Permeability of normal and glucose-6-phosphate dehydrogenase deficient erythrocytes to glutathione.
    Srivastava SK; Beutler E
    Biochem Biophys Res Commun; 1967 Sep; 28(5):659-64. PubMed ID: 6053190
    [No Abstract]   [Full Text] [Related]  

  • 38. Biochemical heterogeneity in glutathione synthetase deficiency.
    Spielberg SP; Garrick MD; Corash LM; Butler JD; Tietze F; Rogers L; Schulman JD
    J Clin Invest; 1978 Jun; 61(6):1417-20. PubMed ID: 659603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism of pantethine in cystinosis.
    Wittwer CT; Gahl WA; Butler JD; Zatz M; Thoene JG
    J Clin Invest; 1985 Oct; 76(4):1665-72. PubMed ID: 4056044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of the effectiveness of cysteamine and phosphocysteamine in elevating plasma cysteamine concentration and decreasing leukocyte free cystine in nephropathic cystinosis.
    Smolin LA; Clark KF; Thoene JG; Gahl WA; Schneider JA
    Pediatr Res; 1988 Jun; 23(6):616-20. PubMed ID: 3393396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.